Skip to main content
PMC home page
Molecular Medicine logoLink to Molecular Medicine
. 1996 May;2(3):358–366.

AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines.

G J Nuovo 1, M L Alfieri 1
PMCID: PMC2230156  PMID: 8784788

Abstract

BACKGROUND: We recently showed that acquired immunodeficiency syndrome (AIDS) dementia is associated with activated infection of microglia, neurons, and astrocytes by HIV-1. However, it is doubtful whether infection per se is responsible for the dramatic symptoms associated with AIDS dementia. The purpose of this study was to determine the histologic distribution of messenger RNAs (mRNAs) of several cytokines that have been implicated in AIDS pathogenesis and to correlate this expression pattern with the in situ localization of polymerase chain reaction (PCR)-amplified HIV-1 nucleic acids in the central nervous system (CNS). MATERIALS AND METHODS: HIV-1 DNA was detected by PCR in situ hybridization. HIV-1 RNA and cytokine expression, including tumor necrosis factor alpha (TNF), inducible nitric oxide synthetase (iNOS), and macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta mRNA were detected by reverse transcriptase (RT) in situ PCR. RESULTS: Amplified viral DNA was detected in each of the seven HIV-1-positive cases and in none of the five negative controls. In people with AIDS dementia, many HIV-1 DNA-positive cells were detected in regions of the CNS that corresponded to clinical symptomatology. In AIDS patients with minimal CNS involvement, rare HIV-1-infected microglial cells were noted. Viral RNA was detected primarily in cases of AIDS dementia. TNF, iNOS, MIP-1 alpha and MIP-1 beta expression localized to tissues from AIDS dementia cases where HIV-1 infected cells were plentiful. Colocalization experiments showed that these cytokines were transcribed mostly by viral-negative cells. CONCLUSIONS: These results suggest that two key elements in AIDS dementia are massive productive viral infection, involving microglia, neurons, and astrocytes, and concomitant stimulation of cytokine transcription in the neighboring uninfected cells.

Full text

PDF
358

Images in this article

361FIG. 1
on p.361
362FIG. 2
on p.362
363FIG. 3
on p.363
364FIG. 4
on p.364

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagasra O., Hauptman S. P., Lischner H. W., Sachs M., Pomerantz R. J. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med. 1992 May 21;326(21):1385–1391. doi: 10.1056/NEJM199205213262103. [DOI] [PubMed] [Google Scholar]
  2. Buttery L. D., Evans T. J., Springall D. R., Carpenter A., Cohen J., Polak J. M. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab Invest. 1994 Nov;71(5):755–764. [PubMed] [Google Scholar]
  3. Cvetkovich T. A., Lazar E., Blumberg B. M., Saito Y., Eskin T. A., Reichman R., Baram D. A., del Cerro C., Gendelman H. E., del Cerro M. Human immunodeficiency virus type 1 infection of neural xenografts. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5162–5166. doi: 10.1073/pnas.89.11.5162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6368–6371. doi: 10.1073/pnas.88.14.6368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dubrovsky L., Ulrich P., Nuovo G. J., Manogue K. R., Cerami A., Bukrinsky M. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention. Mol Med. 1995 Jan;1(2):217–230. [PMC free article] [PubMed] [Google Scholar]
  6. Grant I., Atkinson J. H., Hesselink J. R., Kennedy C. J., Richman D. D., Spector S. A., McCutchan J. A. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med. 1987 Dec;107(6):828–836. doi: 10.7326/0003-4819-107-6-828. [DOI] [PubMed] [Google Scholar]
  7. Harouse J. M., Bhat S., Spitalnik S. L., Laughlin M., Stefano K., Silberberg D. H., Gonzalez-Scarano F. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science. 1991 Jul 19;253(5017):320–323. doi: 10.1126/science.1857969. [DOI] [PubMed] [Google Scholar]
  8. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., Moskowitz M. A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994 Sep 23;265(5180):1883–1885. doi: 10.1126/science.7522345. [DOI] [PubMed] [Google Scholar]
  9. Lipton S. A. HIV-related neurotoxicity. Brain Pathol. 1991 Apr;1(3):193–199. doi: 10.1111/j.1750-3639.1991.tb00659.x. [DOI] [PubMed] [Google Scholar]
  10. Nuovo G. J., Becker J., Burk M. W., Margiotta M., Fuhrer J., Steigbigel R. T. In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J Acquir Immune Defic Syndr. 1994 Sep;7(9):916–923. [PubMed] [Google Scholar]
  11. Nuovo G. J., Gallery F., MacConnell P., Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am J Pathol. 1994 Apr;144(4):659–666. [PMC free article] [PubMed] [Google Scholar]
  12. Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988 Feb 5;239(4840):586–592. doi: 10.1126/science.3277272. [DOI] [PubMed] [Google Scholar]
  13. Seshamma T., Bagasra O., Oakes J. W., Pomerantz R. J. A quantitative reverse transcriptase-polymerase chain reaction for HIV-1-specific RNA species. J Virol Methods. 1992 Dec 1;40(3):331–345. doi: 10.1016/0166-0934(92)90091-q. [DOI] [PubMed] [Google Scholar]
  14. Tornatore C., Nath A., Amemiya K., Major E. O. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol. 1991 Nov;65(11):6094–6100. doi: 10.1128/jvi.65.11.6094-6100.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Watkins B. A., Dorn H. H., Kelly W. B., Armstrong R. C., Potts B. J., Michaels F., Kufta C. V., Dubois-Dalcq M. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science. 1990 Aug 3;249(4968):549–553. doi: 10.1126/science.2200125. [DOI] [PubMed] [Google Scholar]
  16. Weiser B., Peress N., La Neve D., Eilbott D. J., Seidman R., Burger H. Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease. Proc Natl Acad Sci U S A. 1990 May;87(10):3997–4001. doi: 10.1073/pnas.87.10.3997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wiley C. A., Schrier R. D., Nelson J. A., Lampert P. W., Oldstone M. B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089–7093. doi: 10.1073/pnas.83.18.7089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yamada M., Zurbriggen A., Oldstone M. B., Fujinami R. S. Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. J Virol. 1991 Mar;65(3):1370–1376. doi: 10.1128/jvi.65.3.1370-1376.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES